|
TSPAN17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.562800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.347200E-01 |
| Normal-vs-Stage2 |
2.810400E-01 |
| Normal-vs-Stage3 |
4.491600E-01 |
| Normal-vs-Stage4 |
5.051500E-02 |
| Stage1-vs-Stage2 |
2.859200E-01 |
| Stage1-vs-Stage3 |
5.437000E-01 |
| Stage1-vs-Stage4 |
4.233600E-02 |
| Stage2-vs-Stage3 |
6.673600E-01 |
| Stage2-vs-Stage4 |
4.671400E-01 |
| Stage3-vs-Stage4 |
1.802970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.715400E-01 |
| Normal-vs-AfricanAmerican |
2.073600E-01 |
| Normal-vs-Asian |
1.483510E-02 |
| Caucasian-vs-AfricanAmerican |
4.339800E-01 |
| Caucasian-vs-Asian |
3.732000E-02 |
| AfricanAmerican-vs-Asian |
7.653900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.552800E-01 |
| Normal-vs-Female |
1.481030E-01 |
| Male-vs-Female |
2.319200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.140200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.634200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.447400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.250000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.142800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.870400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.232800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.426200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.809500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.771800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.437000E-01 |
| Normal-vs-Grade 2 |
8.076200E-01 |
| Normal-vs-Grade 3 |
1.604570E-01 |
| Normal-vs-Grade 4 |
6.836900E-03 |
| Grade 1-vs-Grade 2 |
5.131000E-01 |
| Grade 1-vs-Grade 3 |
2.064000E-01 |
| Grade 1-vs-Grade 4 |
3.015800E-02 |
| Grade 2-vs-Grade 3 |
2.942500E-02 |
| Grade 2-vs-Grade 4 |
2.592600E-04 |
| Grade 3-vs-Grade 4 |
8.625500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.710100E-02 |
| Normal-vs-ccB subtype |
4.330200E-02 |
| ccA subtype-vs-ccB subtype |
2.93849999999374E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.600200E-01 |
| Normal-vs-N1 |
8.392400E-02 |
| N0-vs-N1 |
7.237600E-02 |
|
|
